Goldman Sachs’s Arrowhead Research ARWR Stock Holding History

Goldman Sachs’s Portfolio ARWR Stock Details ARWR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-10,000	Closed	-$664K	–	6460
2025 Q4	$664K	Buy	+10,000	New	+$490K	﹤0.01%	5425
2020 Q4	–	Sell	-10,000	Closed	-$431K	–	5469
2020 Q3	$431K	Buy	+10,000	New	+$432K	﹤0.01%	4559
2020 Q2	–	Sell	-26,500	Closed	-$762K	–	5186
2020 Q1	$762K	Buy	+26,500	New	+$1.07M	﹤0.01%	3941
2017 Q3	–	Sell	-1,000	Closed	-$2K	–	6648
2017 Q2	$2K	Buy	+1,000	New	+$1.62K	﹤0.01%	6727
2016 Q2	–	Sell	-50,000	Closed	-$241K	–	7009
2016 Q1	$241K	Sell	50,000 -144,900	-74%	-$611K	﹤0.01%	5448
2015 Q4	$1.2M	Buy	+194,900	New	+$1.1M	﹤0.01%	4121
2014 Q2	–	Sell	-9,000	Closed	-$148K	–	6965
2014 Q1	$148K	Buy	+9,000	New	+$158K	﹤0.01%	6245

Other funds holding ARWR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Goldman Sachs's ARWR Position: Q2 2026 in Review

Goldman Sachs reduced its Arrowhead Research (ARWR) stake by 34% in Q2 2026, selling an estimated $43.6M and leaving 1,150,007 shares worth $93.7M. The position accounts for 0.01% of the portfolio, ranked #1266.

Goldman Sachs first reported a position in ARWR in Q3 2013 and has held it in 52 quarters since. The position peaked at $111M in Q4 2025. 502 funds tracked by Wall St. Rank hold ARWR as of Q2 2026.

Goldman Sachs held 1,150,007 shares of Arrowhead Research worth $93.7M as of Q2 2026.
Goldman Sachs sold 589,916 Arrowhead Research shares in Q2 2026, an estimated $43.6M.
Arrowhead Research made up 0.01% of Goldman Sachs's portfolio in Q2 2026, its #1266 holding.
Goldman Sachs first reported a position in Arrowhead Research in Q3 2013 and has held it in 52 quarters since.
Goldman Sachs's Arrowhead Research position peaked at $111M in Q4 2025.
502 funds tracked by Wall St. Rank held Arrowhead Research as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.